University of Washington Developmental AIDS Research Center for Mental Health (UW ARCH)
华盛顿大学心理健康发展艾滋病研究中心 (UW ARCH)
基本信息
- 批准号:10569065
- 负责人:
- 金额:$ 97.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAddressApplied ResearchBehavioral SciencesCaringClinicalCommunitiesComplexConsultationsCountryCountyDevelopmentDiscriminationDissemination and ImplementationEpidemicEpidemiologyGeographyGoalsHIVHIV riskHealthcareHigh PrevalenceIncidenceInequityInfrastructureInstitutionInterventionLeadershipLearningMeasurementMedicalMental DepressionMental HealthMental Health ServicesMental associationMental disordersMentorsMentorshipMethodsMissionModelingPathway interactionsPatientsPersonsPopulations at RiskPovertyPractice based researchPreventionPrevention strategyPrimary CareProcessProviderResearchResearch DesignResearch PersonnelResearch SupportResourcesRiskScienceServicesStatistical MethodsStrategic PlanningSubstance Use DisorderSubstance abuse problemSymptomsTechnologyTestingTrainingTraining ProgramsTraumaUnderrepresented PopulationsUnited StatesUniversitiesVulnerable PopulationsWashingtonWorkantiretroviral therapycollaborative carecommunity engagementcomorbiditydisparity reductiondriving forceeffective therapyevidence baseexperiencehealth care deliveryimplementation scienceinnovationintegrated caremarginalized populationmental health centermortalitymultidisciplinarynext generationnovelperson centeredpsychologicscale upsocial science researchsocial stigmasocioeconomic disadvantagetheoriestherapy developmenttraumatic stresstreatment strategyuser centered design
项目摘要
OVERALL ABSTRACT
The proposed University of Washington (UW) Developmental AIDS Research Center (D-ARC) responds to the
global HIV epidemic at a critical stage. Though more than 21 million people around the world receive antiretroviral
therapy, the most marginalized populations continue to experience high incidence, less access to effective
prevention and care, and greater mortality. Unmet needs persist in high-prevalence countries as well as
“geographic hotspots” in the US such as Seattle's King County. Intersecting stigma, trauma, poverty, and
substance abuse increase risk for mental illnesses, yet the effective treatments available are rarely implemented.
The proposed D-ARC aims to address these challenges by catalyzing research that helps end the
epidemic, with a focus on integrating care for mental disorders into HIV prevention and treatment
strategies. Furthermore, Center investigators will support and apply the science of dissemination and
implementation, with the overall goal of bringing such interventions to scale. The D-ARC aims to fill a gap
in HIV behavioral science research at UW by capitalizing on the considerable strengths of UW's HIV expertise
and bridging this with UW's longstanding leadership in the development and delivery of models of integrated
mental health care. By combining UW expertise in (a) HIV research and (b) mental health care—now siloed
geographically, programmatically, and conceptually—the Center will be a synergistic force capable of realizing
is mission of Implementing Innovative Impactful Integrated Interventions. The proposed infrastructure capitalizes
on the strengths of local expertise and broad ties with global collaborative networks, adding value to UW through
the Center's administration, research support, and training missions, buttressed through additional institutional
commitments of $762,296. Cross-cutting themes of the D-ARC are (a) leveraging local and global bidirectional
pathways to learning and innovation by engaging communities of providers and (b) addressing inequities by
testing research solutions that reduce disparities. Four proposed Cores address the Overall specific aims: 1)
Catalyze and support innovative and impactful research to curb the HIV epidemic, with a focus on integrated
intervention strategies (Administrative Core); 2) Provide needed technical assistance and training on research
design, measurement, theory and novel statistical methods relevant to mental health and HIV research (Methods
Core); 3) Stimulate practice-based research that promotes effective integrated mental health services in HIV
care settings and disseminate findings broadly (Integrated Care Core); and 4) Nurture the Next Generation of
diverse, multidisciplinary HIV researchers through training and innovative mentorship of early stage investigators
and mentors (Developmental Core).
总体摘要
拟议的华盛顿大学艾滋病发展研究中心(D-ARC)回应
全球艾滋病毒疫情正处于关键阶段。尽管全世界有2100多万人接受抗逆转录病毒治疗
治疗中,最边缘化的人群继续经历高发病率,较少获得有效治疗
预防和护理,以及更高的死亡率。未得到满足的需求在高流行率国家以及
美国的“地理热点”,比如西雅图的金县。交叉的耻辱,创伤,贫穷和
物质滥用增加了患精神疾病的风险,但可用的有效治疗很少得到实施。
拟议的D-ARC旨在通过催化有助于结束
流行病,重点是将精神障碍的护理纳入艾滋病毒的预防和治疗
战略。此外,中心调查人员将支持和应用传播科学和
实施,总体目标是使这类干预措施规模化。D-ARC旨在填补一个空白
通过利用威斯康星大学艾滋病毒专业知识的相当大优势,在威斯康星州大学进行艾滋病毒行为科学研究
并将这一点与UW在开发和交付集成车型方面的长期领先地位联系起来
心理健康护理。通过将威斯康星大学在(A)艾滋病毒研究和(B)精神卫生保健方面的专业知识结合起来--现在是孤立的
在地理上、方案上和概念上--中心将成为一股能够实现以下目标的协同力量
是实施创新有效的综合干预措施的使命。拟议的基础设施充分利用了
关于本地专业知识和与全球协作网络的广泛联系的优势,通过以下方式为UW增加价值
该中心的管理、研究支持和培训任务,由更多的机构提供支持
承付款762,296美元。发展区域资源中心的交叉主题是:(A)利用地方和全球双向
通过吸引提供者社区的参与来实现学习和创新的途径以及(B)通过以下方式解决不平等问题
测试缩小差距的研究解决方案。拟议的四个核心涉及总体具体目标:1)
催化和支持遏制艾滋病毒流行的创新和有影响力的研究,重点是综合研究
干预战略(行政核心);2)提供必要的技术援助和研究培训
与心理健康和艾滋病毒研究有关的设计、测量、理论和新的统计方法(方法
核心);3)鼓励以实践为基础的研究,以促进有效的艾滋病毒综合精神健康服务
护理环境和广泛传播研究结果(综合护理核心);以及4)培养下一代
通过对早期调查人员的培训和创新指导,实现多样化、多学科的艾滋病毒研究人员
和导师(发展核心)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan Marie Graham其他文献
Susan Marie Graham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan Marie Graham', 18)}}的其他基金
University of Washington Developmental AIDS Research Center for Mental Health (UW ARCH)
华盛顿大学心理健康发展艾滋病研究中心 (UW ARCH)
- 批准号:
10816852 - 财政年份:2021
- 资助金额:
$ 97.18万 - 项目类别:
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa
美国和撒哈拉以南非洲地区缓释抗逆转录病毒药物治疗的可接受性
- 批准号:
10214487 - 财政年份:2019
- 资助金额:
$ 97.18万 - 项目类别:
Shikamana PrEP: A Community Participatory Approach to Integrating PrEP, Sexual Health, and Mental Health Services for GBMSM in Kenya
Shikamana PrEP:肯尼亚 GBMSM 整合 PrEP、性健康和心理健康服务的社区参与方法
- 批准号:
10064644 - 财政年份:2019
- 资助金额:
$ 97.18万 - 项目类别:
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa
美国和撒哈拉以南非洲地区缓释抗逆转录病毒药物治疗的可接受性
- 批准号:
10020441 - 财政年份:2019
- 资助金额:
$ 97.18万 - 项目类别:
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa
美国和撒哈拉以南非洲地区缓释抗逆转录病毒药物治疗的可接受性
- 批准号:
10437700 - 财政年份:2019
- 资助金额:
$ 97.18万 - 项目类别:
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa
美国和撒哈拉以南非洲地区缓释抗逆转录病毒药物治疗的可接受性
- 批准号:
10678651 - 财政年份:2019
- 资助金额:
$ 97.18万 - 项目类别:
Impact of a novel screening program to detect acute and prevalent HIV infection and reduce HIV transmission
新型筛查计划对检测急性和流行的艾滋病毒感染并减少艾滋病毒传播的影响
- 批准号:
9202511 - 财政年份:2016
- 资助金额:
$ 97.18万 - 项目类别:
Impact of a novel screening program to detect acute and prevalent HIV infection and reduce HIV transmission
新型筛查计划对检测急性和流行的艾滋病毒感染并减少艾滋病毒传播的影响
- 批准号:
9336791 - 财政年份:2016
- 资助金额:
$ 97.18万 - 项目类别:
Endothelial Activation and Microangiopathy in HIV-related Cardiovascular Disease
HIV 相关心血管疾病中的内皮激活和微血管病
- 批准号:
8984228 - 财政年份:2015
- 资助金额:
$ 97.18万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 97.18万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 97.18万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 97.18万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 97.18万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 97.18万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 97.18万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 97.18万 - 项目类别:














{{item.name}}会员




